1-4 of 4
Authors: Cynthia Donovan
Journal Article
1564. Virological Suppression in People with HIV-1 (PWH) Receiving Dolutegravir/Lamivudine Was High and Similar across Age Groups despite Older PWH Having Increased Rates of Comorbidities and Polypharmacy (TANDEM Subgroup Analysis)
Open Forum Infectious Diseases, Volume 10, Issue Supplement_2, December 2023, ofad500.1399, https://doi.org/10.1093/ofid/ofad500.1399
Published: 27 November 2023
Journal Article
Virologic Response to Dolutegravir Plus Lamivudine in People With Suppressed Human Immunodeficiency Virus Type 1 and Historical M184V/I: A Systematic Literature Review and Meta-analysis
Open Forum Infectious Diseases, Volume 10, Issue 11, November 2023, ofad526, https://doi.org/10.1093/ofid/ofad526
Published: 27 October 2023
Journal Article
Changes in Inflammatory and Atherogenesis Biomarkers With the 2-Drug Regimen Dolutegravir Plus Lamivudine in Antiretroviral Therapy–Experienced, Virologically Suppressed People With HIV-1: A Systematic Literature Review
Open Forum Infectious Diseases, Volume 9, Issue 4, April 2022, ofac068, https://doi.org/10.1093/ofid/ofac068
Published: 10 February 2022
Journal Article
Real-World Effectiveness of Simeprevir-containing Regimens Among Patients With Chronic Hepatitis C Virus: The SONET Study
Open Forum Infectious Diseases, Volume 4, Issue 1, Winter 2017, ofw258, https://doi.org/10.1093/ofid/ofw258
Published: 26 December 2016
